comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-14 18:30:13 - browse：8486

Adam's take main illustration — Molly Ferguson/STAT

This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks.

A Worst CEO gets some much-needed help

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for degenerative eye diseases. The deal never happened. I heard from many Ocular investors who were frustrated and angry about Mattesich’s poor job performance. He ended up earning a spot last year on my worst biopharma CEO list. It was an easy pick.

On Thursday, Ocular announced a meaningful “leadership update.” Mattessich is still the CEO, but let’s just say the company’s board decided to surround him with new executives and retinal experts with proven track records of getting stuff done.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Seattle police shoot person suspected in downtown stabbing

focus

explore

WSS

Startup Neumora takes a novel depression drug to Phase 3

WHO calls for emergency meeting on new China virus, as cases spread

Startup Neumora takes a novel depression drug to Phase 3

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

India sets sights on home

knowledge

comprehensive

A Worst CEO gets some much-needed help

focus

Peter Hotez and the public health issue of online harassment

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

At least 13 dead in Texas as scorching temps continue

Man who had jail sentence commuted by Trump arrested again

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Doctors find melanoma drugs effective against rare brain cancer

The cancer drug shortage isn’t new — and neither are the solutions

Sanders adds drug shortage policies to pandemic preparedness bill

Novavax promises a turnaround & Lilly roils the obesity market

Ebola public health emergency is over, WHO declares

focus

Researchers separate signal from noise in heart wearable data

AI can’t replace a physician’s gut feeling

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Medical experts are missing from AI regulatory conversations

Medicare to cover more brain scans for Alzheimer’s patients

India sets sights on home

focus

explore

knowledge

explore